Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-15-000890
Filing Date
2015-03-17
Accepted
2015-03-17 16:06:00
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1516420.htm 20-F 2390267
2 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 10082
3 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 10241
4 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 7906
5 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 7756
6 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 4106
7 logo.jpg GRAPHIC 3650
14 img1.jpg GRAPHIC 48429
  Complete submission text file 0001178913-15-000890.txt   11121180

Data Files

Seq Description Document Type Size
8 INSTANCE DOCUMENT fomx-20141231.xml EX-101.INS 1498671
9 TAXONOMY EXTENSION SCHEMA fomx-20141231.xsd EX-101.SCH 54856
10 TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20141231_cal.xml EX-101.CAL 71507
11 TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20141231_def.xml EX-101.DEF 255796
12 TAXONOMY EXTENSION LABEL LINKBASE fomx-20141231_lab.xml EX-101.LAB 961050
13 TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20141231_pre.xml EX-101.PRE 452567
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36621 | Film No.: 15706399
SIC: 2833 Medicinal Chemicals & Botanical Products